Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Revenue Summary of Scilex Holding Company

Scilex Holding Company's latest annual revenue in 2023 was 46.74 Million USD , up 22.9% from previous year.
Scilex Holding Company's latest quarterly revenue in 2024 Q2 was 16.37 Million USD , up 50.4% from previous quarter.
Scilex Holding Company reported a annual revenue of 38.03 Million USD in annual revenue 2022, up 21.45% from previous year.
Scilex Holding Company reported a annual revenue of 31.31 Million USD in annual revenue 2021, up 32.92% from previous year.
Scilex Holding Company reported a quarterly revenue of 16.37 Million USD for 2024 Q2, up 50.4% from previous quarter.
Scilex Holding Company reported a quarterly revenue of 10.58 Million USD for 2023 Q1, down -11.22% from previous quarter.

Annual Revenue Chart of Scilex Holding Company (2023 - 2019)

Historical Annual Revenue of Scilex Holding Company (2023 - 2019)

Year	Revenue	Revenue Growth
2023	46.74 Million USD	22.9%
2022	38.03 Million USD	21.45%
2021	31.31 Million USD	32.92%
2020	23.56 Million USD	12.01%
2019	21.03 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	10.88 Million USD	-19.15%
2024 Q2	16.37 Million USD	50.4%
2023 Q1	10.58 Million USD	-11.22%
2023 Q3	10.11 Million USD	-19.59%
2023 Q2	12.58 Million USD	18.9%
2023 FY	46.74 Million USD	22.9%
2023 Q4	13.46 Million USD	33.06%
2022 Q2	7.92 Million USD	16.35%
2022 Q1	6.81 Million USD	-17.56%
2022 FY	38.03 Million USD	21.45%
2022 Q4	11.91 Million USD	4.76%
2022 Q3	11.37 Million USD	43.54%
2021 FY	31.31 Million USD	32.92%
2021 Q1	7.82 Million USD	32.92%
2021 Q4	8.26 Million USD	-0.71%
2021 Q3	8.32 Million USD	6.29%
2021 Q2	7.82 Million USD	0.0%
2020 Q3	5.89 Million USD	0.0%
2020 Q1	5.89 Million USD	12.01%
2020 FY	23.56 Million USD	12.01%
2020 Q4	5.89 Million USD	0.0%
2020 Q2	5.89 Million USD	0.0%
2019 Q2	5.25 Million USD	0.0%
2019 Q3	5.25 Million USD	0.0%
2019 FY	21.03 Million USD	0.0%
2019 Q1	5.25 Million USD	0.0%
2019 Q4	5.25 Million USD	0.0%

Peer Revenue Comparison of Scilex Holding Company

Name	Revenue	Revenue Difference
Amgen Inc.	28.19 Billion USD	99.834%
AstraZeneca PLC	45.81 Billion USD	99.898%
Biogen Inc.	9.83 Billion USD	99.525%
Gilead Sciences, Inc.	27.11 Billion USD	99.828%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	46.74 Million USD	0.0%